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Electron capture dissociation (ECD) and collision-induced dissociation (CID), the two com-
plementary fragmentation techniques, are demonstrated to be effective in the detection and
localization of the methionine sulfoxide [Met(O)] residues in peptides using Fourier transform
ion cyclotron resonance (FTICR) mass spectrometry. The presence of Met(O) can be easily
recognized in the low-energy CID spectrum showing the characteristic loss of methanesulfenic
acid (CH3SOH, 64 Da) from the side chain of Met(O). The position of Met(O) can then be
localized by ECD which is capable of providing extensive peptide backbone fragmentation
without detaching the labile Met(O) side chain. We studied CID and ECD of several
Met(O)-containing peptides that included the 44-residue human growth hormone-releasing
factor (GRF) and the human atrial natriuretic peptide (ANP). The distinction and complemen-
tarity of the two fragmentation techniques were particularly remarkable in their effects on
ANP, a disulfide bond-containing peptide. While the predominant fragmentation pathway in
CID of ANP was the loss of CH3SOH (64 Da) from the molecular ion, ECD of ANP resulted
in many sequence-informative products, including those from cleavages within the disulfide-
bonded cyclic structure, to allow for the direct localization of Met(O) without the typical
procedures for disulfide bond reduction followed by ™SH alkylation. (J Am Soc Mass
Spectrom 2003, 14, 605–613) © 2003 American Society for Mass Spectrometry
Methionine (Met) has a sulfur-containing sidechain that is susceptible to oxidation. Metoxidation in proteins plays a prominent role
in aging and age-related degenerative diseases [1–4].
Met oxidation in calmodulin results in its impaired
function in calcium signaling, which is associated with
the loss of calcium homeostasis in aged brain [5, 6]. The
oxidation of Met-35 in the -amyloid peptide (A )
contributes to the insolubility and stability of A , and
has implications in Alzheimer’s disease [7, 8]. However,
increasing evidence also suggests that Met oxidation is
an important mechanism in cellular regulation. Under
physiological conditions, the oxidation of Met to methi-
onine sulfoxide [Met(O)] can be reduced (to Met) by
methionine sulfoxide reductase (MSRA). The Met oxi-
dation-reduction process has been found to play a key
role in the activation-deactivation cycle of several cru-
cial signaling proteins and the maintenance of homeo-
static balance in physiological systems [9, 10]. Hoshi
and co-workers showed that the methionine oxidation-
reduction process modulates the activities of potassium
channel proteins, which play key roles in the cellular
signal transduction activities of excitable cells in the
brain, heart and muscle [11].
Despite its significance in cellular functions and
implications for various pathological conditions, Met
oxidation has been largely overlooked in protein struc-
tural characterization. This is partly due to the fact that
methionine sulfoxide residues are reduced, and de-
tected as methionines in traditional Edman sequencing
procedures [12, 13]. In addition, Met oxidation can be
artificially introduced during sample preparation, puri-
fication and analysis [14, 15, 20], which presents another
degree of complexity in characterization of Met oxida-
tion in proteins.
Several mass spectrometry (MS)-based methods
have recently been introduced to characterize Met(O) in
proteins and peptides, overcoming the limitations of the
conventional protein analysis methods, such as Edman
degradation, gel electrophoresis and amino acid analy-
sis [13–23]. Among the MS-based techniques, tandem
MS (MS/MS) [24] is particularly attractive; the peptide
sequence and the position of Met(O) can be directly
determined through the gas-phase fragmentation [14],
usually through collision-induced dissociation (CID) (a
popular technique currently implemented on most
commercial MS/MS instruments). A distinct fragmen-
tation pathway in CID of Met(O)-containing peptides is
the neutral loss of 64 Da from the precursor and/or
product ions [14, 15, 18]. The characteristic neutral loss
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of 64 Da corresponds to the ejection of methanesulfenic
acid (CH3SOH, 64 Da) from the side chain of Met(O)
(Scheme 1) [18, 28]. The loss of 64 Da is unique, in
proteins and peptides, to Met(O), and is particularly
useful in differentiating between Met(O) and phenylal-
anine (both residues have the same nominal mass of 147
Da) in MS/MS peptide sequencing. However, this low-
energy pathway can further inhibit the backbone se-
quence fragmentation by CID, especially for larger
polypeptides. In fact, the complete MS/MS character-
ization of Met(O) using CID has so far been limited to
small peptides, such as those from enzymatic digestion
[14, 15].
Electron capture dissociation (ECD) [29–35] has re-
cently emerged as a powerful alternative in MS/MS of
multiply charged proteins and peptides generated by
electrospray ionization (ESI) [36] using Fourier trans-
form ion cyclotron resonance (FTICR) mass spectro-
metry [37]. ECD, a technique based on partial neutral-
ization of multiply-protonated ions with electrons,
typically renders extensive inter-residue backbone
cleavage to yield c and z fragment ions, in contrast to
the b and y fragment ions produced from the amide
bond cleavage by conventional energetic fragmentation
methods, including CID and infrared multiphoton dis-
sociation (IRMPD) [25–27, 38]. Furthermore, ECD is a
nonergodic fragmentation technique, i.e., the intramo-
lecular energy randomization is slower than the ECD
cleavage processes. This unique nonergodic feature has
been exemplified by the ability of ECD in preserving the
labile side chain modifications groups on the peptide
backbone fragments [39–44], in contrast to CID and
other conventional fragmentation techniques which
typically eject the labile modifications first, as does the
loss of CH3SOH from Met(O).
Herein, we demonstrate that the combined data from
CID and ECD spectra can be used to quickly detect and
localize the Met(O) residues in a series of peptides,
including one with an internal disulfide bond.
Experimental
High purity solvents were purchased from Fisher Sci-
entific (Springfield, NJ). Peptides were obtained from
Bachem Biosciences Inc. (King of Prussia, PA) and used
without additional purification. Hydrogen peroxide
(H2O2) was obtained from Sigma (St. Louis, MO). The
oxidized form of –MSH was prepared by reaction with
equal molar concentration (1:1) of hydrogen peroxide at
37 °C for 30 min. Samples were dissolved in water/
methanol/acetic acid (49:49:2, vol/vol/vol) at a concen-
tration of 5 M, and were nanosprayed [45] from the
PicoTips (New Objective, Inc., Woburn, MA).
In order to perform ECD experiments, the 3 tesla
Finnigan NewStar Fourier transform ion cyclotron res-
onance mass spectrometer (Finnigan FT/MS, Bremen,
Germany) was modified. The electron gun assembly on
the commercial instrument was removed, and installed
in the fringing magnetic field region (0.8 m away from
the ICR cell) on the side opposite to that of the ESI
source. Ions generated by nanospray were externally
accumulated outside of the magnet in a rf-only octopole
for 1 s and then transferred through electrostatic lenses
into the trapped ion cell [46]. The precursor ions were
first isolated by stored-waveform inverse Fourier trans-
form (SWIFT) ejection [47]. Subsequent to a short pulse
of N2 collision gas for ion cooling, the isolated ions were
irradiated with low-energy (0.5 eV) electrons from the
heated-filament of the electron gun for 1 s. The product
ions were then subjected to chirp excitation and broad-
band detection. Generally, an average of 50 time-do-
main transients was obtained with an Odyssey data
system.
In sustained off-resonance irradiation (SORI) [48]
CID experiments, the SWIFT-isolated precursor ions
were collisionally activated using 20 Vp-p sustained
off-resonance irradiation at 1.5 kHz off-resonance
from the frequency of precursor ion, 0.1 s after the
pulsed introduction of N2 collision gas (a peak pressure
reached 5  106 torr in the analyzer vacuum cham-
ber).
CID experiments were also performed on the LCQ
Deca (ThermoFinnigan Co., San Jose, CA), a quadru-
pole ion trap mass spectrometer equipped with an ESI
source. The voltage of electrospray needle was set at 4.5
kV. The heated capillary was maintained at 250 °C and
held at a potential of 14 V. For all ion-trap MS/MS
experiments, the relative collision energy was set at 30%
(Vp-p  0.4–1.0 V), depending on the mass of the
precursor ions.
Results and Discussion
Adrenocorticotropic Hormone (ACTH) Fragment
4-9
Among the several CID techniques developed in
FTICR, sustained off-resonance irradiation (SORI) [48]
has the highest fragmentation efficiency for dissociating
multiply charged peptides and proteins [27]. Figure 1a
is the SORI-CID spectrum of [M  2H]2 of the Met-
oxidized ACTH 4-9, M(O)EHFKF, showing the typical
y- and b-type fragments by CID. The molecular ion
[M  2H]2 and the product ions b4 and b5 are accom-
panied by the loss of CH3SOH (64 Da); the averaged
exact mass of 64.002 is consistent with CH3SOH (calcu-
lated mass 63.998). The fragmentation map shown in
Figure 1a indicates that the SORI-CID spectrum alone
Scheme 1
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contains all information for detecting and localizing the
Met(O) in this small peptide. For comparison, CID was
also performed on a quadrupole ion trap MS (LCQ
Deca), the resulting spectrum (not shown) was very
similar to that of SORI-CID on FTICR, showing the
same y- and b-ions as well as the losses of 64 Da from
both [M  2H]2 and the product ions (b4 and b5). In
contrast, the ECD spectrum (Figure 1b) shows the
amine bond cleavage products, c3, c4, c5, z4, and z5, as
well as the abundant charge-reduced ion [MH e].
No loss of 64 Da from the molecular or product ions is
observed in the ECD spectrum. The retention of the
labile side chain of Met(O) on the backbone fragment
ions is attributed to the nonergodic nature of ECD
[29–33], and is consistent with the ECD results on other
labile post-translational modifications [39–44]. Besides
the c, z product ions, the losses of NH3 and 82 Da (the
side chain loss of histidine residue [49]) are also ob-
served.
Human Growth Hormone-Releasing Factor (GRF)
SORI-CID of the Met-oxidized human GRF only yields
limited backbone fragmentation (Figure 2a), with 12 out
of total 43 inter-residue bonds being cleaved. The most
abundant product ions (b25
3, b37
4, y11
3, and y19
4) arise
from the cleavages at the C-terminal sides of asparic
acid (D) and glutamic acid (E) residues, the favorable
cleavage sites in CID. The peaks corresponding to the
loss of CH3SOH (64 Da) from [M  7H]
7and three
product ions (y19
4, y42
6, and b37
4) are observed. In con-
trast, ECD offers far more extensive backbone fragmen-
tation (Figure 2b), with 41 of the total 43 inter-residue
bonds being cleaved. Of the c, z fragment ions, 32 are
complementary pairs whose masses sum to that of the
molecular ion. No loss of 64 Da is observed. The
position of Met(O)-27 can be unequivocally determined
by the two complementary pairs of ECD product ions,
c26
3/z18
2 and c27
3/z17
2. The product maps of CID and
ECD are summarized in Figure 3.
–Melanocyte-Stimulating Hormone (–MSH)
CID and ECD experiments were performed on both the
native (reduced) –MSH and the Met-oxidized
–MSH(O). [M  4H]4 at m/z 665.8 for –MSH (Mr 
2659.2), and [M  4H]4 at m/z 669.8 for –MSH(O)
(Mr 2675.2) are dominant signals in their full-scan MS
spectra. The mass increase of 16 Da for –MSH(O)
indicates that the one oxygen atom has been added by
Figure 1. (a) SORI-CID and (b) ECD FTICR spectra of SWIFT-isolated [M  2H]2 of M(O)EHFKF.
The noise signals are marked with an asterisk. The peak with the number sign is an adduct species not
removed by SWIFT excitation.
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the oxidation reaction. SORI-CID of the MSH(O) re-
sulted in the typical elimination of 64 Da from [M 
4H]4 and several product ions (data not shown). The
ECD spectra obtained for [M  4H]4 of the –MSH
and –MSH(O) are shown in Figure 4a and b. As shown
in the inset of Figure 4b, ECD cleaved all inter-residue
bonds of –MSH(O), except for the N-terminal sides of
three proline residues, which are impervious to the
ECD due to the cyclic structure of proline [29–33]. The
expanded ECD spectra of –MSH and –MSH(O) (Fig-
ure 4c) show that the position of Met(O)-11 can be
unequivocally determined from the mass shifts (16 Da
for one oxygen atom) of c12
2 and z12
2 ions.
Atrial Natriuretic Peptide (ANP)
The human ANP is a 28 amino acid peptide with a 17
amino acid ring closed by a disulfide bond between Cys-7
and Cys-23. The structure of Met-oxidized ANP(O) is:
SLRRSSCFGGRM(O)DRIGAQSGLGCNSFRY. The pre-
Figure 2. (a) SORI-CID and (b) ECD FTICR spectra of SWIFT-isolated [M  7H]7 of the
Met-oxidized human growth hormone-releasing factor (GRF).
Figure 3. Product maps indicating the cleavage sites in SORI-CID and ECD of the human growth
hormone-releasing factor (GRF).
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dominant fragmentation pathway in SORI-CID of
ANP(O) is the loss of CH3SOH (64 Da) from the
molecular ion [M  5H]5 (Figure 5a). No appreciable
backbone fragmentation or disulfide bond cleavage is
observed in the CID spectrum. It is well known that
disulfide bonds are generally resistant to cleavage by
low-energy CID [50], thus reduction of disulfide bonds
with dithiothreitol (DTT) followed by –SH alkylation is
necessary before MS/MS analysis. ECD of ANP, how-
ever, resulted in 14 backbone cleavages, including six
from within the cyclic structure. Each of the product
ions from cleavages within the cyclic structure (c10, c12,
c16, c18, c19, z10, z11, and z12) arises from ECD cleavage of
two bonds: A backbone amine bond and a disulfide
bond. None of the Met(O)-containing products (c12, c16,
c18, and c19) is accompanied by the loss of CH3SOH (64
Da). The ability to cleave disulfide bonds is a distinctive
feature of ECD. In fact, the disulfide bond cleavage is
favored over backbone bond cleavage in ECD [30]. The
mechanism for the disulfide bond cleavage by ECD is
still under investigation. It has been suggested by
McLafferty and co-workers that disulfide bond cleav-
age is likely due to the high affinity of the –S–S– site for
the Hatom (from neutralization of a proton by electron
capture), to form a hypervalent intermediate that rap-
idly lead to the dissociation of disulfide bond [30]. The
gas-phase disulfide bond cleavage by ECD holds the
promise of direct sequencing of disulfide-containing
peptides by MS/MS, thus eliminating the need for time-
and material-consuming procedures of disulfide reduc-
tion and –SH alkylation.
[Sar9, Met(O2)11]-Substance P
Methionine sulfone (MetO2) can be formed from Met(O)
in the presence of a strong oxidant. MetO2 is very stable,
and is biologically irreversible [9]. The SORI-CID spec-
trum (Figure 6a) shows the typical b and y fragment
ions, with some being accompanied by H2O and NH3
losses. In contrast to Met(O), no diagnostic neural loss
indicative of MetO2 is observed, which has been noted
previously [14]. ECD cleaves all inter-residue bonds,
except for the N-terminal sides of the two prolines. The
ECD fragmentation pattern (Figure 6b) of this modified
substance P is very similar to that of the native sub-
stance P (RPKPQQFFGLM-NH2) [51]. Note Sar [Sar-
Figure 4. ECD FTICR spectra of SWIFT-isolated [M  4H]4 of (a) –MSH and (b) –MSH (O). (c)
The expanded ECD spectra showing the mass shifts of c12
2 and z12
2 in –MSH and –MSH(O). ECD
product map of –MSH(O) is depicted in (b).
609J Am Soc Mass Spectrom 2003, 14, 605–613 ECD AND CID OF PEPTIDES CONTAINING RESIDUES
cosine: –N(CH3)–CH2–CO–] is the only other amino
acid (besides proline) with a backbone tertiary nitrogen
in a peptide that has been studied by ECD. The pres-
ence of c9 ion indicates the cleavage of the N-terminal
side of Sar, supporting the explanation given by McLaf-
ferty and co-workers [30, 31] for why the N-terminal
side of proline can not be cleaved by ECD: The N™C
bond in proline may indeed be cleaved by ECD, but the
peptide backbone is still connected through the proline
side chain.
Conclusions
ECD and CAD are complementary fragmentation
techniques that provide “easy-to-interpret” spectra
for quickly identifying and localizing the Met(O)
residues in peptides. The characteristic elimination of
CH3SOH (64 Da) in CID serves as a signature tag for
the presence of Met(O) in peptides. ECD then offers
extensive backbone fragmentation without detaching
the labile side chain, to allow for the direct localiza-
tion of the Met(O) residues. The accurate mass mea-
surement of FTICR/MS can also assist in the un-
equivocal determination of Phe and Met(O), as these
two residues share the same nominal mass (147 Da)
but differ in exact mass by 0.033 Da (Phe, 147.0684;
Met(O), 147.0354). With higher magnetic field FTICR
instruments, the approach described here should be
equally applicable to identify and localize methionine
oxidation in proteins, helping to better understand
Figure 5. (a) SORI-CID and (b) ECD spectra of SWIFT-isolated [M  5H]5 of ANP(O). The isotopic
resolution as shown in the zoom view of the ECD spectrum is crucial in determining the charge states
and identifying the product ions. (c) ECD product map of ANP(O).
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the physiological and pathological roles of this over-
looked post-translational modification.
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